| cetyl palmitate | CETYL PALMITATE | 5ZA2S6B08X | OINTMENT / TOPICAL | NA | | Exact identifier — unii candidate 4 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SOLUTION / ORAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | PASTE / TOPICAL | 2.5 %w/w | | Exact identifier — unii candidate 18 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INFILTRATION | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | | 33750 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IONTOPHORESIS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / ORAL | | 9120 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRA-ARTICULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| caffeine | CAFFEINE | 3G6A5W338E | GRANULE / ORAL | NA | | Exact identifier — unii candidate 3 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | | 265 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IRRIGATION | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | | Exact identifier — unii candidate 20 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CAPSULE, EXTENDED RELEASE / ORAL | 4.53 mg | | Exact identifier — unii candidate 18 equally ranked IID candidates |
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | | Exact identifier — unii candidate 77 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, EMULSION / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SYRUP / ORAL | 71 mg/5ml | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | | 1 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / NASAL | 20 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRADERMAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | CREAM / VAGINAL | | 100 mg | Exact identifier — unii candidate 11 equally ranked IID candidates |
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | | 3 mg | Exact identifier — unii candidate 77 equally ranked IID candidates |
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | OINTMENT / TOPICAL | 2 %w/w | | Exact identifier — unii candidate 13 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SOFT TISSUE | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | | 32400 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | | Exact identifier — unii candidate 77 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| cetyl palmitate | CETYL PALMITATE | 5ZA2S6B08X | SOLUTION / TOPICAL | 0.05 %w/w | | Exact identifier — unii candidate 4 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, LIQUID FILLED / ORAL | 1.5 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-AMNIOTIC | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | JELLY / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION, CONCENTRATE / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / ENDOTRACHEAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / RESPIRATORY (INHALATION) | 8 %w/v | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETHRAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | LOTION / TOPICAL | 5 %w/w | | Exact identifier — unii candidate 13 equally ranked IID candidates |
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | | 6 mg | Exact identifier — unii candidate 77 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAVASCULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 5.4 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| caffeine | CAFFEINE | 3G6A5W338E | SOLUTION / OPHTHALMIC | 2 %w/w | | Exact identifier — unii candidate 3 equally ranked IID candidates |
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUSPENSION / ORAL | | 125 mg | Exact identifier — unii candidate 13 equally ranked IID candidates |
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | GEL / TOPICAL | 26 %w/w | | Exact identifier — unii candidate 18 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | | 58 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / TOPICAL | 0.1 %w/v | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | AEROSOL, FOAM / TOPICAL | 0.55 %w/w | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| peg-100 stearate | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | | 552 mg | Exact identifier — unii candidate 3 equally ranked IID candidates |
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | | Exact identifier — unii candidate 77 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / BUCCAL | | 5 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SPRAY / TOPICAL | 4.58 %w/w | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |